While more research is needed, the study suggests that there may be some risks in addition to benefits of using GLP-1s in people with breast cancer and obesity who are taking hormonal therapy
What Results Can Patients Expect From Medical Weight Loss
Tirzepatide activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors simultaneously
Inne produkty w tej kategorii Zestawy Promocyjne
Water, L-carnitine tartrate, filler (glycerin), choline bitartrate, thickener (guar gum), peach flavor, preservatives (potassium sorbate, sodium benzoate), sweetener (potassium acesulfame), vitamin B6